The effects of vitamin C supplementation on pre-eclampsia in Mulago Hospital, Kampala, Uganda: a randomized placebo controlled clinical trial

Table 5 Neonatal outcomes between the vitamin and placebo groups

Characteristic	Vitamin C (N = 415)	Placebo (N = 418)	Risk ratio	P value
Characteristic	n (%)	n (%)	Risk ratio	P value
Birth weight				0.7
<2500 gm	46 (11.1)	43 (10.3)	1.07 (0.72-1.59)
≥2500 gm	369 (88.9)	375 (89.7)	1.07 (0.72-1.59)
Apgar score				0.4
<7	41 (9.9)	35 (8.4)	1.17 (0.76-1.81)
≥7	374 (90.1)	383 (91.6)	1.17 (0.76-1.81)
Admission to special care unit				0.07
Yes	41 (9.9)	27 (6.5)	1.53 (0.95-2.43)	0.07
Still birth				0.9
Yes	19 (4.6)	19 (4.5)	1.01 (0.54-1.87)	0.9
Early neonatal death				0.4
Yes	7 (1.7)	10 (2.4)	0.71 (0.27-1.83)	0.4
Abortion				0.9
Yes	9 (2.2)	9 (2.2)	1.01 (0.40-2.51)	0.9
Preterm delivery				0.7
Yes	47 (11.3)	51 (12.2)	0.92 (0.63-1.34)	0.7

ISSN: 1471-2393